mesa laboratories announces change in auditing firm after merger

Mesa Laboratories , Inc. (NASDAQ:MLAB), a $560 million market cap company based in Lakewood, Colorado, has announced a change in its independent registered public accounting firm. According to InvestingPro data, the company maintains a GOOD financial health score despite recent challenges, including negative earnings in the last twelve months. This shift follows the merger of its previous auditor, Moss Adams LLP, with Baker Tilly US, LLP. The merger took effect on June 3, 2025, leading Moss Adams to resign as Mesa Laboratories’ auditors. The company, which generates annual revenue of $241 million and has maintained dividend payments for 23 consecutive years, faces some financial challenges with its current ratio at 0.63.

The Audit Committee of Mesa Laboratories’ Board of Directors has approved Baker Tilly as the company’s new independent registered public accounting firm. This decision was made following the merger notification, and Baker Tilly will now assume auditing responsibilities for the company.

Moss Adams’ audit report on Mesa Laboratories’ consolidated financial statements for the fiscal year ending March 31, 2025, did not contain any adverse opinions or disclaimers. Want deeper insights into Mesa Laboratories’ financial health and performance metrics? InvestingPro subscribers have access to over 30 additional financial indicators and exclusive analysis. Additionally, there were no disagreements between Mesa Laboratories and Moss Adams regarding accounting principles, practices, or procedures during the fiscal year and the subsequent interim period through June 3, 2025.

Mesa Laboratories confirmed that there were no consultations with Baker Tilly regarding accounting principles or audit opinions during the same period. The company also stated that there were no reportable events requiring disclosure under Item 304(a)(1)(v) of Regulation S-K.

The company has provided Moss Adams with a copy of the current report filed with the Securities and Exchange Commission (SEC) and requested a letter stating agreement with the disclosed statements. This letter, dated June 5, 2025, is included as Exhibit 16.1 in the Form 8-K filing.

This information is based on a press release statement from Mesa Laboratories, Inc.

In other recent news, Mesa Laboratories has declared a quarterly dividend of $0.16 per share. This dividend is set to be paid on June 16, 2025, to shareholders who are on record as of May 30, 2025. The announcement aligns with Mesa’s ongoing financial activities and capital allocation strategy. Mesa Laboratories continues to provide updates on its financial developments to shareholders and the broader market. The company has issued forward-looking statements about expected revenue growth and operational results, although these are subject to risks and uncertainties. These statements cover a variety of topics, including profit margins and market conditions, and are based on current information. Mesa Laboratories has cautioned that actual results may differ from these projections due to various factors. Investors are advised to consider these potential variations, as outlined in the company’s Annual Report and other filings with the Securities and Exchange Commission.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.